Anders Kronstrom, n/a

Chief Operating Officer
Infant Bacterial Therapeutics, Sweden

Poster(s):

• 498 - Correlating Sustained Feeding Tolerance (SFT) to Adverse Outcomes During Randomized Administration of L. reuteri for the Prevention of NEC and Improved Feeding Tolerance in Preterm Infants
  Monday, April 25, 2022

  3:30 PM – 6:00 PM US MT